[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354225-105":59,"doc-detail-354225-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","leveraging-dietary-interventions-to-benefit-patients-with-hematologic-malignancies-and-clonal-hematopoiesis","Leveraging Dietary Interventions to Benefit Patients with Hematologic Malignancies and Clonal Hematopoiesis","","Diet is a modifiable factor that shapes multiple pathways relevant to hematologic malignancy, including systemic inflammation, immune cell function, gut microbiota composition, and cancer cell metabolism. The translation of preclinical findings into clinical practice remains early, yet increasing focus targets dietary interventions as supportive and disease-modifying care. This review synthesizes mechanistic rationale and current clinical evidence across clonal hematologic disorders. Anti-inflammatory patterns, Mediterranean diet, weight management, and microbiome-restoring fiber/plant-based strategies show preliminary clinical signals, while larger rigorously designed trials are required.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/leveraging-dietary-interventions-to-benefit-patients-with-hematologic-malignancies-and-clonal-hematopoiesis/354225/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/leveraging-dietary-interventions-to-benefit-patients-with-hematologic-malignancies-and-clonal-hematopoiesis/354225.png","ImageObject",300,407,{"name":92,"@type":93},"Stanley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What mechanisms connect dietary interventions to hematologic malignancies?","Question",{"text":112,"@type":113},"Diet may influence disease-driving inflammation, obesity-associated risks, and gut microbiota homeostasis, which together can affect immune activity and cancer-related metabolism.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why is the Mediterranean diet highlighted in this review?",{"text":117,"@type":113},"Mediterranean dietary patterns have been shown to reduce pro-inflammatory cytokines and may dampen the inflammatory environment that supports clonal expansion.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence is discussed for dietary strategies in clinical trials?",{"text":121,"@type":113},"Early-phase trials in conditions such as multiple myeloma, acute lymphoblastic leukemia, and myeloproliferative neoplasms indicate feasibility and provide preliminary signals, supporting the need for larger confirmatory studies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354225,1790435004,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Review  \nLeveraging Dietary Interventions to Benefit Patients with Hematologic Malignancies and Clonal Hematopoiesis  \nCamille Brzechffa 1 and Angela G. Fleischman 1,2,3, *  \nAcademic Editor: Luisa Cimmino  \nReceived: 19 March 2026  \nRevised: 9 May 2026  \nAccepted: 11 May 2026  \nPublished: 14 May 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 School of Medicine, University of California, Irvine, CA 92697, USA; [cbrzechf@hs.uci.edu](cbrzechf@hs.uci.edu)  \n[2](2 Division of Hematology/Oncology)[ Division of Hematology/Oncology](2 Division of Hematology/Oncology), [UC Irvine Health](UC Irvine Health), [Irvine](Irvine), [CA 92697](CA 92697), [USA](USA)  \n3 Chao Family Comprehensive Cancer Center, University of California, Irvine, CA 92697, USA  \n* Correspondence: [agf@uci.edu](agf@uci.edu)  \nAbstract  \nDiet is a modifiable factor that influences multiple pathways relevant to hematologic malignancy, including systemic inflammation, immune cell activity, gut microbiota composition, and cancer cell metabolism. Translation of preclinical findings into clinical practice for hematologic malignancies remains nascent, although momentum is building to evaluate dietary interventions as a component of supportive and disease-modifying care. This review examines the mechanistic rationale for dietary interventions across the spectrum ofclonal hematologic disorders and synthesizes current clinical evidence. Anti-inflammatory dietary patterns, particularly the Mediterranean diet, have demonstrated reductions in pro-inflammatory cytokines and may attenuate the inflammatory milieu that fuels clonal expansion. Obesity, which elevates the risk of developing hematologic malignancies and worsens clinical outcomes in diseases such as acute lymphoblastic leukemia (ALL) and acute myeloid leukemia, may be addressed through calorie-restricted, low-fat, or plantbased dietary strategies. Gut microbiota dysbiosis induced by chemotherapy represents another target, with high-fiber and plant-based diets showing promise in restoring microbial diversity and potentially enhancing treatment efficacy. Early-phase clinical trials in multiple myeloma, acute lymphoblastic leukemia, and myeloproliferative neoplasms have established feasibility and yielded preliminary signals warranting larger confirmatory studies. Larger, rigorously designed trials are needed to establish dietary interventions as legitimate therapeutic tools in the management of hematologic malignancies.  \nKeywords: dietary intervention; Mediterranean diet; plant-based diet; gut microbiome; clonal hematopoiesis; CHIP; myeloproliferative neoplasm; multiple myeloma; acute leukemia; inflammation; obesity  \n1. Introduction  \nIt has long been recognized that diet and nutrition are influential factors affecting human health and functioning. Diet and nutrition are increasingly being explored as a means to augment current therapies, slow disease progression, and improve quality of life across a range of health conditions including cancer. Preclinical studies in mice [1,2] as well as systematic reviews [3–5] have demonstrated the benefits of nutritional supplements or dietary interventions in various cancers including head and neck cancer, breast cancer, and lung cancer in improving treatment efficacy and clinical outcomes post-treatment. Diet may modulate cancer via multiple mechanisms, including altering immune cell activity, changing gut microbiota composition, and manipulating cancer cell metabolism. Although  \npreclinical data provide a compelling rationale that diet could similarly impact hematologic malignancies, clinical evaluation in this setting has lagged behind solid tumors and remains an emerging area of investigation. Caveats apply when extending findings from solid-tumor studies to hematologic disease, given fundamental differences in","cbCaipq0XcwqwS2Y","https://ap.wps.com/l/cbCaipq0XcwqwS2Y","pdf",711980,21,"English","# Abstract\n# 1. Introduction\n# 2. Inflammation and Hematologic Malignancies\n## 2.1. Hematologic Malignancies Are Fueled by Inflammation","[{\"question\":\"What mechanisms connect dietary interventions to hematologic malignancies?\",\"answer\":\"Diet may influence disease-driving inflammation, obesity-associated risks, and gut microbiota homeostasis, which together can affect immune activity and cancer-related metabolism.\"},{\"question\":\"Why is the Mediterranean diet highlighted in this review?\",\"answer\":\"Mediterranean dietary patterns have been shown to reduce pro-inflammatory cytokines and may dampen the inflammatory environment that supports clonal expansion.\"},{\"question\":\"What evidence is discussed for dietary strategies in clinical trials?\",\"answer\":\"Early-phase trials in conditions such as multiple myeloma, acute lymphoblastic leukemia, and myeloproliferative neoplasms indicate feasibility and provide preliminary signals, supporting the need for larger confirmatory studies.\"}]","Leveraging Dietary Interventions to Benefit Patients with Hematologic Malignancies and Clonal Hematopoiesis | PDF",1790109620,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6db6e663bd779f32448b3cbe0fc4a553.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fa7053c217e881faab4d7011684e0e57.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f175f388d1a9ccd3f0db2322e4624ccd.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df9916f5ae19a1a190252e5a4a67555e.webp",980,1385]